John Shannon

John Shannon

Chief Executive OfficeratXeris Biopharma Holdings· In proxies 2021–2025

Pay in FY2025Xeris Biopharma Holdings stock +131.6% the same year

John Shannon was paid $5.0M in FY2025 (Dec). Xeris Biopharma Holdings stock rose 131.6% that year.

Pay$100 in the stock at the end of FY20 → $63
Pay is from the Summary Compensation Table of each Xeris Biopharma Holdings proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Xeris Biopharma HoldingsPublic company · 5 yr
    • Chief Executive Officer2021 – Present · 5 yrStock in role +95%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?